What is she best known for?
The fields of study she is best known for:
- Gene
- Immune system
- Cytokine
The scientist’s investigation covers issues in Immunology, Mast cell, Eosinophil, Molecular biology and Fibroblast.
Her study in Inflammation, Allergic inflammation, Allergy, Cytokine and Immune system is carried out as part of her Immunology studies.
Her Mast cell research is multidisciplinary, incorporating elements of Biochemistry, Interleukin 33, Prostaglandin D2, Cell biology and Histamine.
The study incorporates disciplines such as Death Receptors, Apoptosis induction and Caspase activation in addition to Cell biology.
Her work carried out in the field of Eosinophil brings together such families of science as Eosinophilia, Kinase and Granulocyte.
Her study in Fibroblast is interdisciplinary in nature, drawing from both Fibrosis, Matrix metalloproteinase and Tryptase.
Her most cited work include:
- Role of reactive oxygen species (ROS) in apoptosis induction (1961 citations)
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY (1273 citations)
- The human mast cell (320 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Immunology, Mast cell, Eosinophil, Cell biology and Fibroblast.
Her work in Allergic inflammation, Allergy, Inflammation, Immunoglobulin E and Immune system is related to Immunology.
Her studies deal with areas such as Pathology, Interleukin 33, Molecular biology, Degranulation and Histamine as well as Mast cell.
Her research integrates issues of Eosinophilia and Cytokine in her study of Eosinophil.
Her Cell biology study integrates concerns from other disciplines, such as Receptor and Apoptosis.
Her Fibroblast research focuses on Fibrosis and how it connects with Nerve growth factor.
She most often published in these fields:
- Immunology (52.23%)
- Mast cell (35.47%)
- Eosinophil (18.99%)
What were the highlights of her more recent work (between 2017-2021)?
- Immunology (52.23%)
- Immune system (8.38%)
- Inflammation (13.41%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Immunology, Immune system, Inflammation, Allergy and Allergic inflammation.
Her research is interdisciplinary, bridging the disciplines of Microbiome and Immunology.
Her work deals with themes such as Receptor, Innate immune system, Cell type and Cytokine, which intersect with Inflammation.
Her Allergic inflammation research is multidisciplinary, relying on both Cell surface receptor, In vitro, Tryptase and Peritonitis.
Her Eosinophil research includes elements of Mast cell, Ex vivo and Evolutionary biology.
Her Mast cell research is multidisciplinary, incorporating perspectives in Mitochondrion, Inhibitory effect, Dexamethasone and Histamine.
Between 2017 and 2021, her most popular works were:
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY (1273 citations)
- Microbe-host interplay in atopic dermatitis and psoriasis. (52 citations)
- A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29. (39 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Immune system
- Internal medicine
Francesca Levi-Schaffer mainly focuses on Immunology, Inflammation, Immune system, Drug discovery and Drug.
The Immunology study combines topics in areas such as Microbiome and Cancer.
Her Inflammation research includes themes of Immunoglobulin E, Peritoneal cavity, Tryptase and Peritonitis.
Francesca Levi-Schaffer combines subjects such as Thymic stromal lymphopoietin, Cytokine, Eosinophilia, Tolerability and Receptor complex with her study of Immunoglobulin E.
Her Immune system research incorporates themes from Haematopoiesis, CD48, Binding properties and Function.
Her Drug discovery study integrates concerns from other disciplines, such as Therapeutic strategy, Risk analysis and Human proteins.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
